Status | Study |
Recruiting |
Study Name: Identification of Undiagnosed Gaucher Disease Condition: Gaucher Disease Date: 2012-10-26 Interventions: Other: Enzyme analysis |
Suspended |
Study Name: Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease Condition: Type I Gaucher Disease Date: 2011-10-27 Interventions: Drug: Ambroxol Ambroxol at a dose level of 187.5 or 225 mg/day will be given once daily by mouth for 2 m |
Completed |
Study Name: A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease Condition: Gaucher Disease Date: 2011-08-22 Interventions: Drug: Taliglucerase alfa Taliglucerase infusion every two weeks for 21 months |
Completed |
Study Name: A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease Condition: Gaucher Disease Date: 2011-08-04 Interventions: Drug: Taliglucerase alfa Taliglucerase alfa for infusion every two weeks for 24 months |
Completed |
Study Name: Cellular and Molecular Mechanisms Governing Bone Marrow Stem Cells in Gaucher Disease Condition: Gaucher Disease Date: 2011-06-22 Interventions: Other: Bone marrow and blood sampling Bone marrow and blood sampling |
Recruiting |
Study Name: Home Therapy With VPRIV in Gaucher's Disease Condition: Gaucher Disease Date: 2011-05-17 |
Completed |
Study Name: Exploration of Immunity in Gaucher Disease Condition: Gaucher Disease Date: 2011-05-06 |
Completed |
Study Name: Validating a New Severity Score System for Adults With Type 1 Gaucher Disease (GD1) Condition: Gaucher Disease Date: 2010-05-31 Interventions: Drug: Imiglucerase Imiglucerase intravenous infusions regardless of dose or schedule of administration. |
Completed |
Study Name: A Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease Condition: Gaucher Disease Date: 2010-05-26 Interventions: Drug: Taliglucerase alfa Taliglucerase alfa for infusion every two weeks for 12 months |
Completed |
Study Name: A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE) Condition: Gaucher Disease Date: 2010-02-23 Interventions: Drug: Eliglustat tartrate Oral Capsule in 50 mg or 100 mg dosages |